White paper: Analytical insights to advance biopharmaceutical development

  1. 26th Jun, 2024

Ingenza has a comprehensive suite of validated analytical methods and assays that can be readily employed to fully characterise both small molecules and biologics targets throughout all stages of bioprocess development and optimisation.

We aim to deliver high quality results for our customers that satisfy product specification criteria with confidence, accuracy and precision.

This white paper was written by Fraser Brown, Head of Chemistry at Ingenza. To read more about Fraser and his work at Ingenza, please visit our team page.

To access this content, please fill in your details below.